Drugs & Targets FDA grants Breakthrough Device designation to Natera’s Signatera test May 10, 2019Vol.45 No.19
Drugs & Targets Caris Life Sciences receives FDA Breakthrough Device designation for MI Transcriptome companion diagnostic test May 10, 2019Vol.45 No.19
Drugs & Targets European Commission approves Lorviqua in previously-treated ALK-positive advanced NSCLC May 10, 2019Vol.45 No.19
Drugs & Targets Arcus Biosciences and Strata Oncology announce clinical development collaboration for anti-PD-1 antibody May 10, 2019Vol.45 No.19
Drugs & Targets CHMP issues positive opinion on Talzenna for Talzenna in breast cancer indication May 03, 2019Vol.45 No.18
Drugs & Targets CHMP issues positive opinion for Libtayo for squamous cell carcinoma May 03, 2019Vol.45 No.18
Drugs & Targets CHMP issues positive opinion for Lynparza in maintenance therapy in ovarian cancer May 03, 2019Vol.45 No.18
